CIK 0000899923 · Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 870494517
- Phone
- 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-14 | Bisaro Paul Director | Purchase | +7,500 | $3.69 | $28K | 97,441 |
| 2026-03-09 | Raha Samraat S. President and CEO | Purchase | +40,000 | $5.00 | $200K | 493,104 |
| 2026-02-27 | Phanstiel S. Louise Director | Purchase | +48,000 | $4.66 | $224K | 281,951 |
| 2026-02-26 | Phanstiel S. Louise Director | Purchase | +50,407 | $4.80 | $242K | 233,951 |
| 2026-02-25 | Phanstiel S. Louise Director | Purchase | +6,100 | $4.74 | $29K | 183,544 |
Page 1 of 1 · 5 trades